Matthew Frankel

1.3k total citations
31 papers, 942 citations indexed

About

Matthew Frankel is a scholar working on Epidemiology, Hepatology and Genetics. According to data from OpenAlex, Matthew Frankel has authored 31 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Hepatology and 9 papers in Genetics. Recurrent topics in Matthew Frankel's work include Hepatitis C virus research (7 papers), Liver Diseases and Immunity (6 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Matthew Frankel is often cited by papers focused on Hepatitis C virus research (7 papers), Liver Diseases and Immunity (6 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Matthew Frankel collaborates with scholars based in United States, United Kingdom and Netherlands. Matthew Frankel's co-authors include Olaf Schneewind, Dominique Missiakas, Laura J. Knoll, Yvonne G. Y. Chan, William J. Sandborn, Stephan R. Targan, James N. Lowder, Vanina Dengler Haunreiter, Antoni P. A. Hendrickx and Gert Van Assche and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Matthew Frankel

27 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Frankel United States	17	335	299	264	243	179	31	942
Gavan Holloway Australia	16	252 0.8×	644 2.2×	192 0.7×	173 0.7×	221 1.2×	26	1.1k
David P. J. Turner United Kingdom	22	312 0.9×	251 0.8×	146 0.6×	537 2.2×	108 0.6×	46	1.2k
Robert Naso United States	17	635 1.9×	597 2.0×	161 0.6×	325 1.3×	230 1.3×	27	1.4k
Azeem Mehmood Butt Pakistan	15	496 1.5×	219 0.7×	53 0.2×	233 1.0×	78 0.4×	30	990
James E. Estep United States	19	688 2.1×	449 1.5×	325 1.2×	202 0.8×	146 0.8×	22	1.2k
M. Azim Ansari United Kingdom	21	447 1.3×	484 1.6×	90 0.3×	509 2.1×	74 0.4×	61	1.4k
Peng Xiao United States	20	275 0.8×	395 1.3×	110 0.4×	307 1.3×	621 3.5×	70	1.4k
Anupam Mukherjee India	20	314 0.9×	639 2.1×	90 0.3×	265 1.1×	155 0.9×	72	1.3k
Wendy W. Yeh United States	16	164 0.5×	491 1.6×	63 0.2×	413 1.7×	295 1.6×	47	1.1k
Sharon Cookson United Kingdom	15	181 0.5×	252 0.8×	106 0.4×	351 1.4×	322 1.8×	20	1.1k

Countries citing papers authored by Matthew Frankel

Since Specialization

Citations

This map shows the geographic impact of Matthew Frankel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Frankel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Frankel more than expected).

Fields of papers citing papers by Matthew Frankel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Frankel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Frankel. The network helps show where Matthew Frankel may publish in the future.

Co-authorship network of co-authors of Matthew Frankel

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Frankel. A scholar is included among the top collaborators of Matthew Frankel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Frankel. Matthew Frankel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bowlus, Christopher L., Douglas Thorburn, Stephen T. Barclay, et al.. (2025). Nebokitug, an Anti-chemokine (C-C Motif) Ligand 24 Monoclonal Antibody, in Patients With Primary Sclerosing Cholangitis: A Phase 2 Study. The American Journal of Gastroenterology.

Aricha, Revital, Inbal Mishalian, Matthew Frankel, et al.. (2024). The Role of CCL24 in Primary Sclerosing Cholangitis: Bridging Patient Serum Proteomics to Preclinical Data. Cells. 13(3). 209–209. 8 indexed citations

Aricha, Revital, Matthew Frankel, John M. Lawler, et al.. (2024). Machine Learning Identifies Key Proteins in Primary Sclerosing Cholangitis Progression and Links High CCL24 to Cirrhosis. International Journal of Molecular Sciences. 25(11). 6042–6042. 4 indexed citations

Mor, Adi, Scott L. Friedman, Sharon Hashmueli, et al.. (2024). Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 Studies. Drug Safety. 47(9). 869–881. 8 indexed citations

Berg, Michael G., Kelly E. Coller, Matthew Frankel, et al.. (2016). Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection. Journal of Hepatology. 64(2). S420–S420.

Frankel, Matthew, Kenn Forberg, Kelly E. Coller, et al.. (2016). Development of a high-throughput multiplexed real time RT-PCR assay for detection of human pegivirus 1 and 2. Journal of Virological Methods. 241. 34–40. 10 indexed citations

Berg, Michael G., Deanna Lee, Kelly E. Coller, et al.. (2015). Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection. PLoS Pathogens. 11(12). e1005325–e1005325. 69 indexed citations

Rashid, Nazia, Paul Saenger, Yi‐Lin Wu, et al.. (2014). Switching to Omnitrope® from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System. PubMed. 4(1-2). 27–39. 13 indexed citations

Frankel, Matthew, et al.. (2014). Release of protein A from the cell wall of Staphylococcus aureus. Proceedings of the National Academy of Sciences. 111(4). 1574–1579. 107 indexed citations

10.

Frankel, Matthew & Olaf Schneewind. (2012). Determinants of Murein Hydrolase Targeting to Cross-wall of Staphylococcus aureus Peptidoglycan. Journal of Biological Chemistry. 287(13). 10460–10471. 71 indexed citations

11.

Frankel, Matthew, Antoni P. A. Hendrickx, Dominique Missiakas, & Olaf Schneewind. (2011). LytN, a Murein Hydrolase in the Cross-wall Compartment of Staphylococcus aureus, Is Involved in Proper Bacterial Growth and Envelope Assembly. Journal of Biological Chemistry. 286(37). 32593–32605. 62 indexed citations

12.

Sandborn, William J., Matthew Frankel, Daan W. Hommes, et al.. (2010). Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis. Gut. 59(11). 1485–1492. 58 indexed citations

13.

Frankel, Matthew, Brandon M. Wojcik, Andrea C. DeDent, Dominique Missiakas, & Olaf Schneewind. (2010). ABI domain‐containing proteins contribute to surface protein display and cell division in Staphylococcus aureus. Molecular Microbiology. 78(1). 238–252. 36 indexed citations

14.

Frankel, Matthew & Laura J. Knoll. (2009). The Ins and Outs of Nuclear Trafficking: Unusual Aspects in Apicomplexan Parasites. DNA and Cell Biology. 28(6). 277–284. 31 indexed citations

15.

Sandborn, William J., Jean‐Frédéric Colombel, Matthew Frankel, et al.. (2009). 387 A Placebo-Controlled Trial of Visilizumab in Patients with Intravenous (IV) Steroid Refractory Ulcerative Colitis (UC). Gastroenterology. 136(5). A–64. 3 indexed citations

16.

Baumgart, Daniel C., James N. Lowder, Stephan R. Targan, William J. Sandborn, & Matthew Frankel. (2009). Transient Cytokine-Induced Liver Injury Following Administration of the Humanized Anti-CD3 Antibody Visilizumab (HuM291) in Crohn's Disease. The American Journal of Gastroenterology. 104(4). 868–876. 18 indexed citations

17.

Frankel, Matthew, Dana G. Mordue, & Laura J. Knoll. (2007). Discovery of parasite virulence genes reveals a unique regulator of chromosome condensation 1 ortholog critical for efficient nuclear trafficking. Proceedings of the National Academy of Sciences. 104(24). 10181–10186. 38 indexed citations

18.

Plevy, Scott E., Bruce Salzberg, Gert Van Assche, et al.. (2007). A Phase I Study of Visilizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Severe Steroid-Refractory Ulcerative Colitis. Gastroenterology. 133(5). 1414–1422. 90 indexed citations

19.

Frankel, Matthew. (2005). Major League Problems: Baseball's Broken System of Cuban Defection. Boston College Third World law journal. 25(2). 383. 1 indexed citations

20.

Verbeek, Walter, Matthew Frankel, Steven A. Miles, Jonathan Said, & H. Phillip Koeffler. (1998). Seroprevalence of HHV-8 Antibodies in HIV-Positive Homosexual Men Without Kaposi’s Sarcoma and Their Clinical Follow-Up. American Journal of Clinical Pathology. 109(6). 778–783. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact